Daré Bioscience

(NASDAQ) DARE

Current Price$2.52

Market Cap$40.04M

Since IPO (2017)-96%

5 Year-83%

1 Year-6%

1 Month+49%

Daré Bioscience Financials at a Glance

Market Cap

$40.04M

Revenue (TTM)

$1.03M

Net Income (TTM)

$13.40M

EPS (TTM)

$-1.33

P/E Ratio

-2.07

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Price

$2.52

Volume

10,357

Open

$2.68

Price

$2.52

Volume

10,357

Open

$2.68

Previous Close

$2.75

Daily Range

$2.48 - $2.79

52-Week Range

$1.27 - $9.19

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Price

$2.52

Volume

10,357

Open

$2.68

Previous Close

$2.75

Daily Range

$2.48 - $2.79

52-Week Range

$1.27 - $9.19

DARE News

Daré Bioscience Posts Narrower Q2 Loss

Motley Fool Markets TeamAug 14, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Daré Bioscience

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Sabrina Martucci Johnson, MBA

Website

www.darebioscience.com

Headquarters

San Diego, CA 92122, US

DARE Financials

Key Financial Metrics (TTM)

Gross Margin

-3%

Operating Margin

-13%

Net Income Margin

-13%

Return on Equity

Return on Capital

-2%

Return on Assets

-41%

Earnings Yield

-48.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$40.04M

Shares Outstanding

14.56M

Volume

10.36K

Avg. Volume

496.69K

Financials (TTM)

Gross Profit

$1.42M

Operating Income

$13.55M

EBITDA

$11.40M

Operating Cash Flow

$9.89B

Capital Expenditure

$385.28M

Free Cash Flow

$10.27B

Cash & ST Invst.

$24.71B

Total Debt

$2.66B

Daré Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$1.02M

+1708.4%

Gross Profit

$58.84K

+100.4%

Gross Margin

5.75%

N/A

Market Cap

$40.04M

N/A

Market Cap/Employee

$1.91M

N/A

Employees

N/A

Net Income

$1.44M

+73.8%

EBITDA

$802.23K

+85.1%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$22.06B

+153113.6%

Accounts Receivable

$573.06K

+149.2%

Inventory

$0.00

N/A

Long Term Debt

$5.95M

+688.2%

Short Term Debt

$2.10M

+282.2%

Return on Assets

-41.26%

N/A

Return on Invested Capital

-1.54%

N/A

Free Cash Flow

$1.24M

-73.5%

Operating Cash Flow

$1.44M

-72.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LPTXLeap Therapeutics, Inc.

LPTXLeap Therapeutics, Inc.$0.77-3.15%

ATHAAthira Pharma, Inc.

ATHAAthira Pharma, Inc.$6.75-6.12%

HOTHHoth Therapeutics, Inc.

HOTHHoth Therapeutics, Inc.$0.66-0.90%

AIMDAinos, Inc.

AIMDAinos, Inc.$1.71+0.59%

CTXRCitius Pharmaceuticals, Inc.

CTXRCitius Pharmaceuticals, Inc.$0.64+0.03%

FBLGFibroBiologics, Inc. Common Stock

FBLGFibroBiologics, Inc. Common Stock$1.00-13.36%

ASBPAspire Biopharma Holdings, Inc.

ASBPAspire Biopharma Holdings, Inc.$5.27-5.05%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$16.37+0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.89+0.01%

ODYSOdysight.ai

ODYSOdysight.ai$5.46+0.22%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.23-0.01%

DGXXDigi Power X

DGXXDigi Power X$7.73+0.17%

CRCLCircle Internet Group

CRCLCircle Internet Group$128.37+0.13%

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF

TSDDGraniteShares ETF Trust - GraniteShares 2x Short Tsla Daily ETF$7.08-0.05%

Questions About DARE

What is the current price of Daré Bioscience?

Daré Bioscience is trading at $2.52 per share.

What is the 52-week range for Daré Bioscience?

Over the past 52 weeks, Daré Bioscience has traded between $1.27 and $9.19.

How much debt does Daré Bioscience have?

As of the most recent reporting period, Daré Bioscience reported total debt of $8.05M.

How much cash does Daré Bioscience have on hand?

Daré Bioscience reported $24.71M in cash and cash equivalents in its most recent financial results.

What is Daré Bioscience’s dividend yield?

Daré Bioscience does not currently have a dividend yield.

Daré Bioscience

Daré Bioscience Financials at a Glance

DARE News

Daré Bioscience Posts Narrower Q2 Loss

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Daré Bioscience

DARE Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Daré Bioscience Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About DARE

What is the current price of Daré Bioscience?

What is the 52-week range for Daré Bioscience?

How much debt does Daré Bioscience have?

How much cash does Daré Bioscience have on hand?

What is Daré Bioscience’s dividend yield?

Premium Investing Services